Ocular Signs and Ocular Comorbidities in Monoclonal Gammopathy: Analysis of 80 Subjects
Table 2
Ophthalmic diagnosis in ophthalmic history of control subjects and in patients with monoclonal gammopathy (MG).
Ophthalmic diagnosis
Control (n = 86)
MG (n = 160)
values
Dry eye disease
17 (19.77%)
64 (40.00%)
0.002
Penetrating keratoplasty
0
2 (1.25%)
—
Glaucoma
4 (4.65%)
12 (7.50%)
0.55
Previous cataract surgery
12 (13.95%)
20 (12.50%)
0.90
Cataract
12 (13.95%)
27 (16.88%)
0.54
Posterior cortical cataract
1 (1.16%)
4 (2.50%)
0.47
Without previous ophthalmic diagnosis
22 (25.58%)
66 (41.25%)
0.01
Total
86 (100%)
160 (100%)
—
values refer to results of χ2 test with Yates correction (comparison between both groups). Significant values are in bold. With “0” value, χ2 test could not be calculated.
